MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2

Atsushi Jikuhara, Masanori Yoshii, Hiromi Iwagaki, Shuji Mori, Masahiro Nishibori, Noriaki Tanaka

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Protease-activated receptor-2 (PAR-2) has been demonstrated to be highly expressed in the gastrointestinal tract. In the present study, we investigated the effects of PAR-2 stimulation on the cell signaling and proliferation of DLD-1, a human colon carcinoma cell line, in comparison with the PAR-1 stimulation. PAR-2 stimulation by agonist peptide SLIGKV concentration-dependently induced the increase in [Ca2+]i and the proliferation of DLD-1 whereas the inverse peptide LSIGKV did not. Trypin (10-9 M), an agonist protease for PAR-2, also enhanced the proliferation of DLD-1. The proliferative response of DLD-1 to PAR-2 stimulation was associated with the transient phosphorylation of MEK and MAP kinase, but not p38 MAP kinase and JNK. Inhibition of MEK by PD98059 (50 μM) completely inhibited the proliferation-stimulating effects as well as the phosphorylation of MAP kinase induced by PAR-2 agonist peptide (100 μM) and trypsin (10-9 M). The prolonged treatment with PAR-2 agonist peptide for more than one hour was required for the enhanced proliferative response, suggesting the existence of unknown long-lasting cooperative signaling with MAP kinase cascade. PAR-1 stimulation by the agonist peptide SFLLRN (100 μM) or thrombin (10-8 M) produced Ca2+ signaling, however, the stimulation neither produced the cell proliferative response nor the activation of MEK-MAP kinase cascade. These results indicated that Ca2+ signaling induced by PARs activation was not enough for inducing the cell proliferation in DLD-1 cells and that stimulation of PAR-2 can induce the activation of MEK-MAP kinase cascade, leading to the growth promoting response.

Original languageEnglish
Pages (from-to)2817-2829
Number of pages13
JournalLife Sciences
Volume73
Issue number22
DOIs
Publication statusPublished - Oct 17 2003

Fingerprint

PAR-2 Receptor
Phosphotransferases
Carcinoma
Mitogen-Activated Protein Kinase Kinases
MAP Kinase Kinase Kinases
MAP Kinase Signaling System
Peptides
Phosphorylation
Chemical activation
seryl-leucyl-isoleucyl--glycyl-lysyl-valine
Cell proliferation
Cell Proliferation
Cell signaling
p38 Mitogen-Activated Protein Kinases
Thrombin
Trypsin
Gastrointestinal Tract
Colon
Peptide Hydrolases
Cells

Keywords

  • Colon cancer
  • MAP kinase
  • MEK
  • Protease-activated receptor-2
  • Trypsin

ASJC Scopus subject areas

  • Pharmacology

Cite this

MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2. / Jikuhara, Atsushi; Yoshii, Masanori; Iwagaki, Hiromi; Mori, Shuji; Nishibori, Masahiro; Tanaka, Noriaki.

In: Life Sciences, Vol. 73, No. 22, 17.10.2003, p. 2817-2829.

Research output: Contribution to journalArticle

Jikuhara, Atsushi ; Yoshii, Masanori ; Iwagaki, Hiromi ; Mori, Shuji ; Nishibori, Masahiro ; Tanaka, Noriaki. / MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2. In: Life Sciences. 2003 ; Vol. 73, No. 22. pp. 2817-2829.
@article{57110aaf9a194bd5a66d650f24f0cfdb,
title = "MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2",
abstract = "Protease-activated receptor-2 (PAR-2) has been demonstrated to be highly expressed in the gastrointestinal tract. In the present study, we investigated the effects of PAR-2 stimulation on the cell signaling and proliferation of DLD-1, a human colon carcinoma cell line, in comparison with the PAR-1 stimulation. PAR-2 stimulation by agonist peptide SLIGKV concentration-dependently induced the increase in [Ca2+]i and the proliferation of DLD-1 whereas the inverse peptide LSIGKV did not. Trypin (10-9 M), an agonist protease for PAR-2, also enhanced the proliferation of DLD-1. The proliferative response of DLD-1 to PAR-2 stimulation was associated with the transient phosphorylation of MEK and MAP kinase, but not p38 MAP kinase and JNK. Inhibition of MEK by PD98059 (50 μM) completely inhibited the proliferation-stimulating effects as well as the phosphorylation of MAP kinase induced by PAR-2 agonist peptide (100 μM) and trypsin (10-9 M). The prolonged treatment with PAR-2 agonist peptide for more than one hour was required for the enhanced proliferative response, suggesting the existence of unknown long-lasting cooperative signaling with MAP kinase cascade. PAR-1 stimulation by the agonist peptide SFLLRN (100 μM) or thrombin (10-8 M) produced Ca2+ signaling, however, the stimulation neither produced the cell proliferative response nor the activation of MEK-MAP kinase cascade. These results indicated that Ca2+ signaling induced by PARs activation was not enough for inducing the cell proliferation in DLD-1 cells and that stimulation of PAR-2 can induce the activation of MEK-MAP kinase cascade, leading to the growth promoting response.",
keywords = "Colon cancer, MAP kinase, MEK, Protease-activated receptor-2, Trypsin",
author = "Atsushi Jikuhara and Masanori Yoshii and Hiromi Iwagaki and Shuji Mori and Masahiro Nishibori and Noriaki Tanaka",
year = "2003",
month = "10",
day = "17",
doi = "10.1016/S0024-3205(03)00702-1",
language = "English",
volume = "73",
pages = "2817--2829",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "22",

}

TY - JOUR

T1 - MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2

AU - Jikuhara, Atsushi

AU - Yoshii, Masanori

AU - Iwagaki, Hiromi

AU - Mori, Shuji

AU - Nishibori, Masahiro

AU - Tanaka, Noriaki

PY - 2003/10/17

Y1 - 2003/10/17

N2 - Protease-activated receptor-2 (PAR-2) has been demonstrated to be highly expressed in the gastrointestinal tract. In the present study, we investigated the effects of PAR-2 stimulation on the cell signaling and proliferation of DLD-1, a human colon carcinoma cell line, in comparison with the PAR-1 stimulation. PAR-2 stimulation by agonist peptide SLIGKV concentration-dependently induced the increase in [Ca2+]i and the proliferation of DLD-1 whereas the inverse peptide LSIGKV did not. Trypin (10-9 M), an agonist protease for PAR-2, also enhanced the proliferation of DLD-1. The proliferative response of DLD-1 to PAR-2 stimulation was associated with the transient phosphorylation of MEK and MAP kinase, but not p38 MAP kinase and JNK. Inhibition of MEK by PD98059 (50 μM) completely inhibited the proliferation-stimulating effects as well as the phosphorylation of MAP kinase induced by PAR-2 agonist peptide (100 μM) and trypsin (10-9 M). The prolonged treatment with PAR-2 agonist peptide for more than one hour was required for the enhanced proliferative response, suggesting the existence of unknown long-lasting cooperative signaling with MAP kinase cascade. PAR-1 stimulation by the agonist peptide SFLLRN (100 μM) or thrombin (10-8 M) produced Ca2+ signaling, however, the stimulation neither produced the cell proliferative response nor the activation of MEK-MAP kinase cascade. These results indicated that Ca2+ signaling induced by PARs activation was not enough for inducing the cell proliferation in DLD-1 cells and that stimulation of PAR-2 can induce the activation of MEK-MAP kinase cascade, leading to the growth promoting response.

AB - Protease-activated receptor-2 (PAR-2) has been demonstrated to be highly expressed in the gastrointestinal tract. In the present study, we investigated the effects of PAR-2 stimulation on the cell signaling and proliferation of DLD-1, a human colon carcinoma cell line, in comparison with the PAR-1 stimulation. PAR-2 stimulation by agonist peptide SLIGKV concentration-dependently induced the increase in [Ca2+]i and the proliferation of DLD-1 whereas the inverse peptide LSIGKV did not. Trypin (10-9 M), an agonist protease for PAR-2, also enhanced the proliferation of DLD-1. The proliferative response of DLD-1 to PAR-2 stimulation was associated with the transient phosphorylation of MEK and MAP kinase, but not p38 MAP kinase and JNK. Inhibition of MEK by PD98059 (50 μM) completely inhibited the proliferation-stimulating effects as well as the phosphorylation of MAP kinase induced by PAR-2 agonist peptide (100 μM) and trypsin (10-9 M). The prolonged treatment with PAR-2 agonist peptide for more than one hour was required for the enhanced proliferative response, suggesting the existence of unknown long-lasting cooperative signaling with MAP kinase cascade. PAR-1 stimulation by the agonist peptide SFLLRN (100 μM) or thrombin (10-8 M) produced Ca2+ signaling, however, the stimulation neither produced the cell proliferative response nor the activation of MEK-MAP kinase cascade. These results indicated that Ca2+ signaling induced by PARs activation was not enough for inducing the cell proliferation in DLD-1 cells and that stimulation of PAR-2 can induce the activation of MEK-MAP kinase cascade, leading to the growth promoting response.

KW - Colon cancer

KW - MAP kinase

KW - MEK

KW - Protease-activated receptor-2

KW - Trypsin

UR - http://www.scopus.com/inward/record.url?scp=0141791069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141791069&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(03)00702-1

DO - 10.1016/S0024-3205(03)00702-1

M3 - Article

C2 - 14511767

AN - SCOPUS:0141791069

VL - 73

SP - 2817

EP - 2829

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 22

ER -